scholarly journals Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome)

2022 ◽  
Vol 157 (1) ◽  
pp. 62-75
Author(s):  
Ryuji Yamamoto ◽  
Satoshi Kawashima
2021 ◽  
Vol 132 ◽  
pp. S147
Author(s):  
Kruti Patel ◽  
Laura Smith ◽  
Tania Seabrook ◽  
Alec Tzianabos ◽  
Lindsay Schulman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document